ResearcherIRCCS Ospedale San RaffaeleActive in the last 2 years
Sara Broggi
Matched on OpenAlex author ID A5055642637. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 4
- Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ctro.2024.100778↗
- Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy. Co-author DOI 10.3389/fonc.2022.983984↗
- Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic … Co-author DOI 10.1016/j.radonc.2020.07.003↗
- Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Co-author DOI 10.1016/j.ejmp.2018.05.013↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nadia Gisella Di Muzio · 4 shared papers, 2018–2024 · strength 0.49
- Paper Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocar… DOI 10.1016/j.ctro.2024.100778↗
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Claudio Fiorino · 4 shared papers, 2018–2024 · strength 0.49
- Paper Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocar… DOI 10.1016/j.ctro.2024.100778↗
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Paolo Passoni · 4 shared papers, 2018–2024 · strength 0.49
- Paper Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocar… DOI 10.1016/j.ctro.2024.100778↗
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Michele Reni · 3 shared papers, 2020–2024 · strength 0.42
- Paper Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocar… DOI 10.1016/j.ctro.2024.100778↗
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Martina Mori · 3 shared papers, 2018–2022 · strength 0.31
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Paper Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and … DOI 10.1016/j.ejmp.2018.05.013↗
- Giovanni Mauro Cattaneo · 2 shared papers, 2018–2022 · strength 0.21
- Paper Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in… DOI 10.3389/fonc.2022.983984↗
- Paper Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and … DOI 10.1016/j.ejmp.2018.05.013↗
- Umberto Peretti · 1 shared paper, 2024 · strength 0.18
- Marina Macchini · 1 shared paper, 2024 · strength 0.18
- Giulio Belfiori · 1 shared paper, 2024 · strength 0.18
- Giulia Orsi · 1 shared paper, 2024 · strength 0.18
- Domenico Tamburrino · 1 shared paper, 2024 · strength 0.18
- Gianpaolo Balzano · 1 shared paper, 2024 · strength 0.18
- Massimo Falconi · 1 shared paper, 2024 · strength 0.18
- Stefano Cascinu · 1 shared paper, 2024 · strength 0.18
- Maria Picchio · 2 shared papers, 2018–2020 · strength 0.17
- Paper Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemo… DOI 10.1016/j.radonc.2020.07.003↗
- Paper Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and … DOI 10.1016/j.ejmp.2018.05.013↗
- R. Calandrino · 1 shared paper, 2018 · strength 0.07
- Maria Luisa Belli · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.